2 Beaten-Down Stocks to Buy on the Dip
Investors haven't been kind to Intuitive Surgical (NASDAQ: ISRG) and Regeneron Pharmaceuticals (NASDAQ: REGN) this year. Both healthcare leaders have encountered company-specific issues that have led to sell-offs. Intuitive Surgical's stock is down 15% this year, while Regeneron has shed 21% of its value.
However, there are excellent reasons to think both companies could rebound, and if that's the case, now might be a wonderful time to purchase their shares on the dip. Here's why I remain bullish on these medical companies.
Image source: Getty Images.
Source Fool.com
Regeneron Pharmaceuticals Inc. Stock
€631.60
-1.700%
The stock is one of the favorites of our community with 37 Buy predictions and 2 Sell predictions.
With a target price of 707 € there is a slightly positive potential of 11.94% for Regeneron Pharmaceuticals Inc. compared to the current price of 631.6 €.
